Ming Cui

434 total citations
19 papers, 319 citations indexed

About

Ming Cui is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming Cui has authored 19 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming Cui's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Mycobacterium research and diagnosis (3 papers). Ming Cui is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Mycobacterium research and diagnosis (3 papers). Ming Cui collaborates with scholars based in China and United States. Ming Cui's co-authors include Rongrong Jing, Yun Jiang, Huimin Wang, Shaoqing Ju, Shaoqing Ju, Feng Wei, Shaoqing Ju, Jingyi Cui, Lurong Zhang and Xinhua Wu and has published in prestigious journals such as American Journal of Physiology-Gastrointestinal and Liver Physiology, Analytical and Bioanalytical Chemistry and Clinical Biochemistry.

In The Last Decade

Ming Cui

19 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Cui China 11 196 178 70 37 33 19 319
Abeba Zewdu United States 8 228 1.2× 133 0.7× 61 0.9× 53 1.4× 23 0.7× 10 311
Liu Zh China 12 158 0.8× 113 0.6× 66 0.9× 41 1.1× 34 1.0× 41 350
Sichuang Tan China 9 149 0.8× 87 0.5× 123 1.8× 44 1.2× 33 1.0× 20 287
Zhiwei Zhao China 13 244 1.2× 178 1.0× 34 0.5× 65 1.8× 26 0.8× 29 358
Kemin Wu China 10 318 1.6× 250 1.4× 70 1.0× 65 1.8× 25 0.8× 19 456
Pei He China 10 172 0.9× 110 0.6× 30 0.4× 62 1.7× 30 0.9× 30 310
Xiaofen Zhou China 11 188 1.0× 132 0.7× 51 0.7× 42 1.1× 39 1.2× 29 358
Yali Min China 5 248 1.3× 143 0.8× 54 0.8× 46 1.2× 21 0.6× 5 348
Tingjie Wang China 9 128 0.7× 82 0.5× 67 1.0× 65 1.8× 67 2.0× 28 295

Countries citing papers authored by Ming Cui

Since Specialization
Citations

This map shows the geographic impact of Ming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Cui more than expected).

Fields of papers citing papers by Ming Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Cui. The network helps show where Ming Cui may publish in the future.

Co-authorship network of co-authors of Ming Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Cui. A scholar is included among the top collaborators of Ming Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Cui. Ming Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cui, Ming, et al.. (2023). Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer. Clinical & Translational Oncology. 25(8). 2532–2544. 14 indexed citations
2.
Jiang, Yun, Jingyi Cui, Ming Cui, & Rongrong Jing. (2023). SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K/AKT pathway. Pathology - Research and Practice. 248. 154646–154646. 29 indexed citations
3.
4.
Cui, Ming, et al.. (2021). Distribution characteristics and influencing factors of homocyteine in an apparently healthy examined population. BMC Cardiovascular Disorders. 21(1). 429–429. 6 indexed citations
5.
Liu, Sinan, et al.. (2021). SLC6A3 as a potential circulating biomarker for gastric cancer detection and progression monitoring. Pathology - Research and Practice. 221. 153446–153446. 10 indexed citations
6.
Jing, Rongrong, et al.. (2020). Determination of serum RP11-731F5.2 as a noninvasive biomarker for gastric cancer diagnosis and prognosis. Pathology - Research and Practice. 216(12). 153261–153261. 8 indexed citations
7.
Wei, Feng, Yun Jiang, Xin Shi, et al.. (2019). LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway. Gastric Cancer. 23(2). 228–240. 37 indexed citations
8.
Cui, Ming, et al.. (2019). Droplet digital PCR for quantification of PML-RARα in acute promyelocytic leukemia: a comprehensive comparison with real-time PCR. Analytical and Bioanalytical Chemistry. 411(4). 895–903. 18 indexed citations
9.
Wei, Feng, et al.. (2019). Evaluating the diagnostic and prognostic value of serum long non-coding RNA CTC-497E21.4 in gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 57(7). 1063–1072. 25 indexed citations
10.
Jing, Rongrong, Huimin Wang, Shaoqing Ju, & Ming Cui. (2018). Reference materials for molecular diagnostics: Current achievements and future strategies. Clinical Biochemistry. 56. 11–17. 7 indexed citations
11.
Ju, Shaoqing, et al.. (2018). Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 56(11). 1828–1837. 23 indexed citations
12.
Cui, Ming, et al.. (2017). A review of the challenge in measuring and standardizing BCR-ABL1. Clinical Chemistry and Laboratory Medicine (CCLM). 55(10). 1465–1473. 7 indexed citations
13.
Cui, Ming, et al.. (2017). Combining Nordtest method and bootstrap resampling for measurement uncertainty estimation of hematology analytes in a medical laboratory. Clinical Biochemistry. 50(18). 1067–1072. 10 indexed citations
14.
Sun, Baolan, Jianhong Shen, Lanchun Ni, et al.. (2016). DNA hypomethylation of CD133 promoter is associated with recurrent glioma. Oncology Reports. 36(2). 1062–1068. 4 indexed citations
15.
Jing, Rongrong, Wen Chen, Huimin Wang, et al.. (2015). Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE. American Journal of Physiology-Gastrointestinal and Liver Physiology. 309(9). G719–G729. 20 indexed citations
16.
Cui, Ming, Mengkang Fan, Rongrong Jing, et al.. (2013). Cell-Free Circulating DNA: A New Biomarker for the Acute Coronary Syndrome. Cardiology. 124(2). 76–84. 55 indexed citations
17.
Jing, Rongrong, Huimin Wang, Ming Cui, et al.. (2011). A sensitive method to quantify human cell-free circulating DNA in blood: Relevance to myocardial infarction screening. Clinical Biochemistry. 44(13). 1074–1079. 21 indexed citations
18.
Jing, Rongrong, Ming Cui, Baolan Sun, Juan Yu, & Huimin Wang. (2010). Tissue-Specific Expression Profiling of Receptor for Advanced Glycation End Products and Its Soluble Forms in Esophageal and Lung Cancer. Genetic Testing and Molecular Biomarkers. 14(3). 355–361. 20 indexed citations
19.
Zhou, Jinxing & Ming Cui. (2008). Neural Network-Based Early Warning System for Debris Flow Disaster in the Three Gorges Reservoir Region. 15. 485–490. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026